Legis Daily

Benay Taub Lung Cancer Research Act

USA119th CongressHR-6319| House 
| Updated: 11/28/2025
Josh Gottheimer

Josh Gottheimer

Democratic Representative

New Jersey

Cosponsors (4)
Eric Swalwell (Democratic)Adelita S. Grijalva (Democratic)Michael Lawler (Republican)Debbie Wasserman Schultz (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill mandates the Secretary of Health and Human Services to establish a Lung Cancer Task Force within the National Institutes of Health. The task force will include representatives from the National Cancer Institute and the National Comprehensive Cancer Control Program of the Centers for Disease Control and Prevention. Its primary duties involve examining disparities in lung cancer research, funding, and patient access to treatments when compared to other diseases, considering the significant number of people affected. The task force will also assess the current level of Federal funding for lung cancer research in relation to the disease's overall burden and review lung cancer screenings across the United States. Within 180 days of the bill's enactment, the Secretary is required to transmit a comprehensive report to Congress. This report must detail the task force's findings and recommendations, specifically including proposals for increasing the level of Federal funding for lung cancer research .
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 28, 2025
Introduced in House
Nov 28, 2025
Referred to the House Committee on Energy and Commerce.
  • November 28, 2025
    Introduced in House


  • November 28, 2025
    Referred to the House Committee on Energy and Commerce.

Health

Benay Taub Lung Cancer Research Act

USA119th CongressHR-6319| House 
| Updated: 11/28/2025
This bill mandates the Secretary of Health and Human Services to establish a Lung Cancer Task Force within the National Institutes of Health. The task force will include representatives from the National Cancer Institute and the National Comprehensive Cancer Control Program of the Centers for Disease Control and Prevention. Its primary duties involve examining disparities in lung cancer research, funding, and patient access to treatments when compared to other diseases, considering the significant number of people affected. The task force will also assess the current level of Federal funding for lung cancer research in relation to the disease's overall burden and review lung cancer screenings across the United States. Within 180 days of the bill's enactment, the Secretary is required to transmit a comprehensive report to Congress. This report must detail the task force's findings and recommendations, specifically including proposals for increasing the level of Federal funding for lung cancer research .
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 28, 2025
Introduced in House
Nov 28, 2025
Referred to the House Committee on Energy and Commerce.
  • November 28, 2025
    Introduced in House


  • November 28, 2025
    Referred to the House Committee on Energy and Commerce.
Josh Gottheimer

Josh Gottheimer

Democratic Representative

New Jersey

Cosponsors (4)
Eric Swalwell (Democratic)Adelita S. Grijalva (Democratic)Michael Lawler (Republican)Debbie Wasserman Schultz (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted